Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Times Interest Earned (2016 - 2025)

Aytu Biopharma (AYTU) has disclosed Times Interest Earned for 13 consecutive years, with -$3.52 as the latest value for Q4 2025.

  • On a quarterly basis, Times Interest Earned fell 123.94% to -$3.52 in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.38, a 2.32% increase, with the full-year FY2025 number at -$0.78, down 148.77% from a year prior.
  • Times Interest Earned was -$3.52 for Q4 2025 at Aytu Biopharma, down from -$2.91 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $2.69 in Q1 2025 to a low of -$3.69 in Q2 2025.
  • A 3-year average of -$1.12 and a median of -$1.42 in 2024 define the central range for Times Interest Earned.
  • Biggest YoY gain for Times Interest Earned was 311.73% in 2025; the steepest drop was 211.53% in 2025.
  • Aytu Biopharma's Times Interest Earned stood at $2.48 in 2023, then tumbled by 163.22% to -$1.57 in 2024, then crashed by 123.94% to -$3.52 in 2025.
  • Per Business Quant, the three most recent readings for AYTU's Times Interest Earned are -$3.52 (Q4 2025), -$2.91 (Q3 2025), and -$3.69 (Q2 2025).